Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (QoQ) (2011 - 2024)
Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (QoQ) (2011 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
| Date | Value |
| Jun 30, 2024 |
-140.07% |
| Mar 31, 2024 |
-146.75% |
| Dec 31, 2023 |
405.56% |
| Nov 30, 2019 |
-677.71% |
| Aug 31, 2019 |
107.22% |
| May 31, 2019 |
-55.11% |
| Feb 28, 2019 |
67.62% |
| Nov 30, 2018 |
-333.39% |
| Aug 31, 2018 |
258.95% |
| May 31, 2018 |
-10.56% |
| Feb 28, 2018 |
-8.70% |
| Nov 30, 2017 |
-206.68% |
| Aug 31, 2017 |
213.17% |
| May 31, 2017 |
32.76% |
| Feb 28, 2017 |
-60.37% |
| Nov 30, 2016 |
5.42% |
| Aug 31, 2016 |
-15.16% |
| May 31, 2016 |
-63.13% |
| Feb 29, 2016 |
-139.04% |
| Nov 30, 2015 |
146.41% |